Literature DB >> 9402093

Total body water and body composition in chronic peritoneal dialysis patients.

W Arkouche1, D Fouque, C Pachiaudi, S Normand, M Laville, E Delawari, J P Riou, J Traeger, M La Ville.   

Abstract

In this investigation, total body water (TBW) in ten chronic peritoneal dialysis patients was studied by deuterium (TBW-2H), skinfold thickness (TBW-ST), Watson formula (TBW-WA), 58% of body weight (TBW-58%), and bioelectrical impedance (TBW-BIA), and these results were compared with the reference oxygen18 (TBW-18O) method. We also analyzed the fat-free mass (FFM) by skinfold thickness (FFM-ST), bioelectrical impedance (FFM-BIA), oxygen18 (FFM-18O), and creatinine kinetics method (FFM-CK). In addition, resting metabolic rate was measured by indirect calorimetry. Compared with TBW-18O, TBW-58% and TBW-BIA were significantly different (P < 0.01). TBW-2H overestimated TBW-18O by 4.3%. TBW-ST and TBW-WA gave slightly greater values than TBW-18O, although these values were nonstatistically significant. The best prediction of total body water from these methods was obtained with the Watson formula. When Kt/V was calculated from these results, the values obtained were statistically greater (BIA, P < 0.001) and smaller (58% BW, P < 0.01) than those obtained with either 18O or Watson formula. The fat-free mass estimation also led to discrepant findings. Indeed, FFM-CK was significantly lower (P < 0.05) as compared with FFM-ST, FFM-BIA, or FFM-18O. Resting metabolic rate was strongly correlated with FFM estimated by skinfold thickness (r = 0.91, P < 0.001), bioelectrical impedance (r = 0.85, P < 0.005), and 18O (r = 0.77, P < 0.01), but not when fat-free mass was estimated by the creatinine kinetic method. The water content of fat-free mass estimated by skinfold thickness was found to be 69.7 +/- 6.9% in these patients, a value lower than the standard 73.2% found in healthy adults. This study confirms that there is an abnormal water distribution in chronic peritoneal dialysis patients. However, when compared with the oxygen18 reference method, the Watson formula allows a reliable estimation of Kt/V.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402093     DOI: 10.1681/ASN.V8121906

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

1.  Effects of branched amino acids supplementation in malnourished elderly with catabolic status.

Authors:  M Bonnefoy; M Laville; R Ecochard; J F Jusot; S Normand; S Maillot; B Lebreton; M Jauffret
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

2.  Association between bioimpedance analysis parameters and left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Salih Inal; Yasemin Erten; Gülay U Okyay; Nuh Ataş; Kürşad Oneç; Cağrı Yayla; Merve Y Tekbudak; Gülşah Sahin; Yusuf Tavil; Sükrü Sindel
Journal:  Int Urol Nephrol       Date:  2014-04-09       Impact factor: 2.370

3.  Efficacy of dialysis in peritoneal dialysis: utility of bioimpedance to calculate Kt/V and the search for a target Kt.

Authors:  G Martínez Fernández; A Ortega Cerrato; J Masiá Mondéjar; A Pérez Rodríguez; F Llamas Fuentes; C Gómez Roldán; Juan Pérez-Martínez
Journal:  Clin Exp Nephrol       Date:  2012-08-11       Impact factor: 2.801

4.  A non-invasive, on-line deuterium dilution technique for the measurement of total body water in haemodialysis patients.

Authors:  Cian Chan; David Smith; Patrik Spanel; Christopher W McIntyre; Simon J Davies
Journal:  Nephrol Dial Transplant       Date:  2008-03-08       Impact factor: 5.992

5.  Bioelectric Impedance Analysis in the Diagnosis of Vesicoureteral Reflux.

Authors:  Meral Torun Bayram; Demet Alaygut; Mehmet Turkmen; Alper Soylu; Salih Kavukcu
Journal:  Iran J Pediatr       Date:  2015-08-24       Impact factor: 0.364

6.  N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.

Authors:  Misa Ikeda; Hirokazu Honda; Keiko Takahashi; Kanji Shishido; Takanori Shibata
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.